Chelation Therapy Side Effects: What to Know Before Treatment

The most common chelation therapy side effects are burning at the IV site, headache, fatigue, nausea and a brief drop in blood pressure, and most fade within 24 to 48 hours of each session. Over a full course, expect gradual loss of essential minerals such as zinc, calcium and magnesium, which is why kidney function, blood counts and mineral levels are checked every 5 to 10 sessions; the gravest risk, a sudden fall in blood calcium, is tied mainly to disodium EDTA given too fast, as a CDC report on three deaths documented (2006).

Chelation therapy works by binding heavy metals and minerals in the bloodstream so they can be excreted by the kidneys. It is a powerful pharmacological intervention, and like all powerful interventions, it carries real side effects that deserve honest discussion.

Too often, the conversation about chelation therapy side effects falls into one of two unhelpful extremes. Proponents minimize the risks, dismissing side effects as “rare” and “minor.” Critics exaggerate them, painting chelation as inherently dangerous. The truth, as usual, is more nuanced.

The agents behind those side effects have several names. EDTA comes as edetate calcium disodium (CaNa2EDTA) and edetate disodium (Na2EDTA); DMSA is also called succimer; DMPS is also called unithiol; and dimercaprol is the older injectable known as BAL. Each one has a different side effect profile, covered agent by agent further down, along with the monitoring and prevention steps a responsible chelation therapy treatment plan should include.

The setting matters as much as the drug. Hospital chelation for confirmed lead poisoning is usually directed by a medical toxicologist or pediatrician, while outpatient “detox” and cardiovascular chelation is mostly offered by integrative, functional medicine and naturopathic practitioners on a cash pay basis.

What to Expect During and After a Chelation Session

A typical chelation course follows a predictable pattern, and most side effects show up at specific points in it. Knowing the timeline helps you separate an ordinary reaction from one that needs a call to your clinician.

1. Before the first session: Your clinician orders baseline labs, usually a comprehensive metabolic panel (CMP) with BUN and creatinine, a CBC, mineral levels and a urinalysis, and reviews your medications, kidney history and pregnancy status.
2. During an IV infusion: A standard EDTA infusion runs slowly, about 1.5 to 3 hours, and the sensations people notice most are stinging along the vein, mild lightheadedness and a metallic or sulfur taste.
3. Right after the infusion: Blood pressure can dip briefly, so clinics typically ask you to rise slowly and stay 10 to 15 minutes before leaving.
4. The next 12 to 48 hours: Fatigue, a dull headache and mild nausea are common and usually clear by the following day, especially with good hydration.
5. Across the full course: Mineral loss builds slowly from session to session, which is why kidney function and mineral levels are rechecked every 5 to 10 sessions rather than only at the start and end.

Oral chelation with DMSA or DMPS follows a different rhythm. Instead of infusion site reactions, people taking capsules more often notice stomach upset, loose stools, a sulfur smell or taste and, in some cases, a skin rash during the days they take the drug.

Common Side Effects (Experienced by Many Patients)

These side effects are frequently reported and generally manageable. They do not typically require stopping treatment, though each one is worth mentioning to the clinician running your infusions.

Burning or Discomfort at the IV Site

The most immediately noticeable side effect during IV chelation is a burning or stinging sensation at the infusion site. This is particularly common with disodium EDTA and is related to the solution’s pH and osmolality. Slowing the infusion rate, warming the IV bag, and ensuring adequate vein access typically reduce this discomfort. Some practitioners add a small amount of lidocaine or procaine to the infusion to minimize local irritation; the TACT protocol included procaine in its infusion bag for this reason.

Redness, swelling or a hard, tender cord along the vein in the days after an infusion can signal phlebitis (vein inflammation). That is less common and should be checked by the clinic, especially if it spreads or comes with fever.

Headache

Headaches during or after chelation sessions are reported by roughly 10-25% of patients. They are usually mild to moderate and resolve within hours. The mechanism likely involves transient shifts in mineral balance and blood vessel tone. Adequate hydration before and during the infusion helps prevent headaches.

Fatigue

Many patients report feeling tired or “washed out” for 12-48 hours after a chelation session. This is one of the most common complaints and may relate to the metabolic work of processing and excreting the chelated metals and minerals through the kidneys. Some patients describe a pattern of fatigue on the day of treatment followed by increased energy on subsequent days.

Fatigue that deepens over several weeks instead of lifting between sessions is a different signal. It can point to iron or zinc depletion or a falling blood count, and it is a reason to ask for repeat labs rather than push through.

Nausea and GI Symptoms

Mild nausea, loss of appetite, and occasionally loose stools are reported by some patients, particularly during the first few sessions. These symptoms are more common with oral chelation agents (DMSA, DMPS) than with IV EDTA. Eating a light meal before treatment and staying well hydrated typically helps.

Transient Hypotension

Blood pressure may drop temporarily during IV chelation, especially with EDTA infusions. This can cause lightheadedness or dizziness, particularly when standing up quickly after an infusion. Patients are typically advised to rise slowly from the treatment chair and remain in the clinic for 10-15 minutes after the infusion ends.

Essential Mineral Depletion: The Most Important Side Effect

This is the side effect that matters most, and the one that separates competent chelation practitioners from careless ones.

Chelation agents are not perfectly selective. While they have stronger binding affinity for toxic heavy metals (lead, mercury, arsenic, cadmium), they also bind and remove essential minerals that your body needs. This is not an unexpected side effect; it is an inherent pharmacological property of chelation chemistry, and the CDC (2006) notes that chelating agents increase excretion of zinc and, in some cases, calcium.

The minerals most commonly depleted by chelation therapy include:

Mineral depletion rarely announces itself early. Muscle cramps, tingling around the mouth or fingers, new hair shedding, changes in taste or a run of colds can all be early signs, and each is worth reporting before the next session rather than after the course ends.

Kidney Monitoring: A Non-Negotiable Safety Requirement

Chelated metals are excreted primarily through the kidneys. This means chelation therapy places a direct workload on renal function, and kidney monitoring is absolutely essential throughout treatment.

Standard kidney monitoring during chelation includes:

• Baseline kidney function tests (BUN, creatinine, eGFR) before initiating treatment
• Repeat kidney function every 5-10 sessions during active treatment
• Urinalysis periodically to check for proteinuria (protein in the urine, which can signal kidney stress)
• Adequate hydration before, during, and after each session (patients should drink extra water on treatment days)

Patients with pre-existing kidney disease (eGFR below 60) are at significantly elevated risk of renal toxicity from chelation. Most responsible chelation practitioners will either decline to treat these patients or use significantly reduced doses with more frequent monitoring. Chelation therapy with normal kidney function is generally well tolerated by the kidneys when appropriate doses and infusion rates are used.

The large trials reflect this caution. The TACT trial enrolled only adults with a serum creatinine of 2.0 mg/dL or less, according to Lamas and colleagues in JAMA (2013), so its reassuring safety results do not extend to people with advanced kidney disease.

Rare but Serious Side Effects

These side effects are uncommon when chelation is properly administered but can be life-threatening when they occur:

Hypocalcemia

Disodium EDTA has a particularly strong affinity for calcium. If infused too rapidly, it can cause an acute drop in ionized calcium levels, potentially leading to cardiac arrhythmia, seizures, and cardiac arrest. This is the most serious acute risk of IV EDTA chelation. The risk is managed by:

• Using calcium disodium EDTA (CaNa2EDTA) instead of disodium EDTA, which largely eliminates the hypocalcemia risk
• Infusing slowly (minimum 1.5-3 hours for a standard dose)
• Never exceeding the recommended dose (typically 50mg/kg, maximum 3 grams per session)
• Monitoring calcium levels in patients receiving disodium EDTA

Deaths from chelation-induced hypocalcemia have occurred, but virtually all documented cases involved either the wrong form of EDTA, excessively rapid infusion, or doses far exceeding recommended limits. A CDC report in MMWR (2006) described three deaths from hypocalcemia during chelation in Texas, Pennsylvania and Oregon, two of them children, and found disodium EDTA was given in at least two cases. When protocols such as those taught by ACAM (American College for Advancement in Medicine) are followed, with the correct agent, dose and infusion time, this risk is very low.

Renal Toxicity

In patients with pre-existing kidney impairment, chelation therapy can accelerate renal decline. Even in patients with normal baseline kidney function, chronic high-dose chelation without adequate hydration and monitoring can theoretically cause tubular damage. This is why kidney function monitoring is non-negotiable.

Bone Marrow Suppression

Rarely, chelation therapy (particularly DMSA) has been associated with decreases in white blood cells or platelets. CBC monitoring during treatment courses helps catch this early. Treatment should be paused if significant drops occur.

Allergic and Skin Reactions

Rash, itching and, rarely, more severe allergic reactions can occur with any chelating agent, and they are reported more often with oral DMSA and DMPS than with EDTA. A new rash, swelling of the lips or face, or trouble breathing during or after a dose needs prompt medical attention, and a known allergy to an agent rules that agent out.

Side Effect Comparison by Chelating Agent

Different chelation agents have different side effect profiles. Here is how the three most commonly used agents compare:

EDTA is the most commonly used IV chelation agent, particularly in the integrative medicine setting for cardiovascular indications and general heavy metal detoxification. Its primary risks involve calcium depletion and kidney stress, both manageable with proper protocols. Calcium disodium EDTA carries far less hypocalcemia risk than disodium EDTA, which is why the form on the order matters.

DMSA (Succimer) is the most commonly used oral chelation agent. It is FDA-approved for lead poisoning in children and is frequently used off-label for mercury and other metals. It is generally considered the gentlest chelation agent but has the highest rate of GI side effects and skin reactions. Dosing schedules and lab checks for capsules are laid out in our DMSA chelation overview.

DMPS (Unithiol) is available in both IV and oral forms. It has a particularly strong affinity for mercury and is favored by some practitioners for mercury-specific chelation. It is not FDA-approved in the United States but is available through compounding pharmacies.

Is Chelation Therapy FDA Approved, and How Strong Is the Evidence?

Chelation therapy is FDA approved for specific poisonings, not for general detox. Edetate calcium disodium and succimer (DMSA) are approved for lead poisoning, and dimercaprol is approved for arsenic, mercury and lead poisoning. According to the CDC (2006), chelation with these agents has been the mainstay of medical care for children with blood lead levels above 45 µg/dL.

Much of the outpatient chelation offered in the United States is off label. The common uses are heart disease, “heavy metal detox” based on symptoms, and conditions such as fatigue or autism, and the evidence for these is thin. The CDC report above notes that the effectiveness of chelation for symptoms of chronic mercury toxicity has not been established.

What did the TACT and TACT2 trials find?

The Trial to Assess Chelation Therapy (TACT), funded by the NIH and published by Lamas et al. in JAMA (2013), randomized 1,708 heart attack survivors to 40 disodium EDTA infusions or placebo. It reported a modest reduction in cardiovascular events, with the authors stating the results were not sufficient to support routine use. The follow-up TACT2 trial (JAMA, 2024) enrolled 959 people with diabetes and a prior heart attack and found no reduction in cardiovascular events, although blood lead levels fell.

For side effects, the trials are the most useful data available. TACT used slow infusions, screened kidney function and included electrolytes in the infusion bag, and the TACT2 investigators also reported a good safety profile. That result describes a supervised research protocol, not every clinic that offers chelation.

What about provoked urine tests?

Many outpatient courses start with a “provoked” or post-challenge urine test, in which a chelator is given before urine is collected. The American College of Medical Toxicology (2010) states that post-challenge urine testing has not been scientifically validated and should not be used as a reason to start or continue chelation. Unprovoked blood and urine metal levels, interpreted against reference ranges, are the accepted way to confirm exposure; our heavy metal testing explainer walks through the differences.

How to Minimize Chelation Therapy Side Effects

The difference between a safe chelation experience and a problematic one usually comes down to the quality of the protocol and the diligence of the monitoring. A responsible chelation protocol includes the following steps:

Mineral Replacement Protocol

• High-quality multimineral supplement taken on non-chelation days (not on the same day as chelation, as it can interfere with the chelation agent)
• Extra zinc: 30-50mg daily during active chelation (zinc is the mineral most consistently depleted)
• Magnesium: 400-600mg daily (glycinate or citrate forms preferred for absorption)
• Calcium: Adequate dietary intake plus supplementation as indicated by lab monitoring
• Iron: Only if labs show declining ferritin or iron saturation; not supplemented routinely
• Monitoring schedule: detailed mineral panel every 5-10 treatment sessions

Hydration Protocol

• Drink at least 32-64 ounces of water on treatment day (before, during, and after the infusion)
• Continue increased hydration for 24-48 hours after each session
• Adequate hydration supports kidney excretion and reduces the risk of renal stress

Physician Monitoring

• Baseline labs: complete metabolic panel (CMP), CBC with differential, mineral levels (zinc, magnesium, copper, iron/ferritin), urinalysis
• Ongoing monitoring: CMP and CBC every 5-10 sessions; mineral levels every 5-10 sessions; urinalysis periodically
• Clinical assessment: Provider should ask about new symptoms at each visit and adjust the protocol accordingly
• Dose adjustment: In patients who experience significant side effects, reducing the dose or increasing the interval between sessions often resolves the issue

Who Should NOT Undergo Chelation Therapy?

Certain conditions make chelation therapy significantly riskier. Contraindications and strong cautions include:

• Significant kidney impairment (eGFR below 60 mL/min): The kidneys cannot safely excrete the chelated metals, increasing the risk of renal toxicity and mineral imbalances.
• Liver failure: Some chelation agents are hepatically metabolized, and impaired liver function can alter drug levels and increase toxicity.
• Pregnancy and breastfeeding: Chelation agents can mobilize stored metals and potentially expose the fetus or infant. Elective chelation should not be given during pregnancy or breastfeeding; the rare exception is severe lead poisoning, which is managed by toxicology specialists in a hospital setting.
• Severe anemia: Chelation can worsen anemia through iron depletion and, rarely, bone marrow effects.
• Known allergy to the specific chelation agent.
• Active infection or sepsis: The physiological stress of chelation is inappropriate during acute illness.

Children deserve a separate mention. The CDC (2006) states that disodium EDTA should never be used to treat lead or other heavy metal poisoning in children, and that calcium disodium EDTA is the only agent recommended for IV chelation in children. One of the deaths in that report was a 5-year-old with autism who received disodium EDTA in a physician’s office, a use the CDC describes as resting on the belief that heavy metals cause autism symptoms.

How to Choose a Chelation Provider and Read the Clinic List

The provider shapes your side effect risk more than any other choice. A well run chelation practice names the exact agent and form it uses, orders baseline labs before the first infusion, repeats kidney and mineral labs on a written schedule, and tells you when it would pause treatment.

The clinicians who offer chelation include medical toxicologists and pediatricians for confirmed poisoning, and integrative physicians (MD or DO), functional medicine doctors and licensed naturopathic doctors for outpatient care. Scope of practice for IV chelation varies by state, so ask who orders the infusion and who is on site while it runs.

You can compare practices that list chelation on the national chelation therapy clinic directory, then use the questions in the box above at a consultation. Regenerated.com is free for patients. Listing order is not paid ranking, Featured slots are labeled and capped, and Verified means credential checks, not spend; the guide to Featured, Verified and organic listings explains each label. Inclusion in the directory is not an endorsement, so the lab and protocol questions still apply to every clinic you contact.

If your concern is a confirmed exposure rather than general detox, the lead poisoning treatment guide and the broader toxic exposure treatment overview describe how testing and referral to a medical toxicologist usually work.

Frequently Asked Questions

Is chelation therapy safe?

Chelation therapy is generally well tolerated when a qualified physician uses the correct agent and dose, infuses slowly, checks kidney function and minerals, and replaces what is lost. In the NIH-funded TACT trial (JAMA, 2013), 16% of the chelation group and 15% of the placebo group stopped infusions because of adverse events. Most serious harms in the chelation literature trace back to practitioner error: the wrong agent, the wrong dose, an infusion that ran too fast, or inadequate monitoring.

How long do chelation therapy side effects last?

Most common side effects of chelation therapy, such as fatigue, headache, nausea and IV site discomfort, resolve within 24 to 48 hours after each session. Mineral depletion works differently. It builds gradually over the course of treatment and can persist or worsen if it is not managed with supplementation, which is why mineral and kidney labs are repeated every 5 to 10 sessions throughout the course, not only at the beginning and end.

Can chelation therapy damage my kidneys?

Chelation therapy at standard doses does not typically damage the kidneys of people with normal baseline kidney function who are well hydrated and monitored. People with pre-existing kidney disease, roughly an eGFR below 60, face a genuine risk of chelation-induced renal toxicity. The TACT trial only enrolled adults with a serum creatinine of 2.0 mg/dL or less, so kidney testing before and during chelation is mandatory, and reduced kidney function calls for specialist care or no chelation.

What does a “healing crisis” or “detox reaction” during chelation actually mean?

A “healing crisis” or “detox reaction” is a label some practitioners use for a temporary worsening of symptoms during chelation, on the idea that mobilized metals cause brief symptoms before they are excreted. Redistributed metals may affect tissues for a short time, but the term is also used to dismiss side effects that need attention. Significant new symptoms should be evaluated medically, because they may signal mineral depletion, kidney stress or another problem that requires dose adjustment or extra monitoring.

What should I expect after my first chelation session?

After a first IV chelation session, most people feel tired or slightly washed out for the rest of the day, and some have a mild headache, nausea or a sore spot at the IV site. Lightheadedness when standing is common in the first 15 minutes, which is why clinics ask you to wait before leaving. Drinking extra water for 24 to 48 hours helps. Fever, muscle spasms, tingling around the mouth, chest symptoms or very little urine are reasons to call the clinic the same day.

Does oral chelation have fewer side effects than IV chelation?

Oral chelation with DMSA (succimer) or DMPS avoids IV site burning and the low calcium risk tied to disodium EDTA, but it is not free of side effects. Oral agents cause more stomach upset, loose stools, sulfur taste and skin rash, and DMSA can occasionally lower white blood cell or platelet counts. Both oral and IV chelation deplete zinc and other minerals, so the same baseline labs, repeat monitoring and mineral replacement apply whichever route your clinician uses.

Related Reading

This article is part of our full guide to chelation therapy. For a full overview of how chelation works, its applications, evidence, and what to expect during treatment, see our pillar article: Chelation Therapy: The Complete Guide.

For agent by agent detail on uses, approval status and how sessions are scheduled, the chelation therapy treatment guide is the companion reference, and you can browse clinics that offer chelation across the US once you know which questions to ask.